Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Expert Rev Anticancer Ther. 2012;12(1):41-49. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is resistant to cytotoxic chemotherapy and is responsible for ...

Cancer cells sometimes travel to faraway organs (like the lungs or liver) by entering the bloodstream. This is more common with aggressive endometrial cancers like serous and clear cell ...

Uterine cancer is the most common gynecological cancer in the United States. It forms in the uterus, which is the hollow, pear-shaped organ in the lower abdomen where a fetus develops and grows.

What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...